key: cord-0880176-gxeb8zxl
authors: Yang, Quanhe; Tong, Xin; Coleman King, Sallyann; Olivari, Benjamin S.; Merritt, Robert K.
title: Stroke Hospitalizations Before and During COVID-19 Pandemic Among Medicare Beneficiaries in the United States
date: 2021-07-29
journal: Stroke
DOI: 10.1161/strokeaha.121.034562
sha: 625eb255ea08151245d4db0e8d2c23647172493f
doc_id: 880176
cord_uid: gxeb8zxl

BACKGROUND AND PURPOSE: Emergency department visits and hospitalizations for stroke declined significantly following declaration of coronavirus disease 2019 (COVID-19) as a national emergency on March 13, 2020, in the United States. This study examined trends in hospitalizations for stroke among Medicare fee-for-service beneficiaries aged ≥65 years and compared characteristics of stroke patients during COVID-19 pandemic to comparable weeks in the preceding year (2019). METHODS: For trend analysis, we examined stroke hospitalizations from week 1 in 2019 through week 44 in 2020. For comparison of patient characteristics, we estimated percent reduction in weekly stroke hospitalizations from 2019 to 2020 during weeks 10 through 23 and during weeks 24 through 44 by age, sex, race/ethnicity, and state. RESULTS: Compared to weekly numbers of hospitalizations for stroke reported during 2019, stroke hospitalizations in 2020 decreased sharply during weeks 10 through 15 (March 1–April 11), began increasing during weeks 16 through 23, and remained at a level lower than the same weeks in 2019 from weeks 24 through 44 (June 7–October 31). During weeks 10 through 23, stroke hospitalizations decreased by 22.3% (95% CI, 21.4%–23.1%) in 2020 compared with same period in 2019; during weeks 24 through 44, they decreased by 12.1% (95% CI, 11.2%–12.9%). The magnitude of reduction increased with age but similar between men and women and among different race/ethnicity groups. Reductions in stroke hospitalizations between weeks 10 through 23 varied by state ranging from 0.0% (95% CI, −16.0%–1.7%) in New Hampshire to 36.2% (95% CI, 24.8%–46.7%) in Montana. CONCLUSIONS: One-in-5 fewer stroke hospitalizations among Medicare fee-for-service beneficiaries occurred during initial weeks of the COVID-19 pandemic (March 1–June 6) and weekly stroke hospitalizations remained at a lower than expected level from June 7 to October 31 in 2020 compared with 2019. Changes in stroke hospitalizations varied substantially by state.

also declined significantly during the early period of the COVID-19 pandemic. [3] [4] [5] [6] [7] [8] [9] The observed reduction in stroke hospitalizations during the COVID-19 pandemic could have significant unintended consequences; each year nearly 800 000 Americans have a new or recurrent stroke (on average 15 000 stroke per week) and ≈150 000 die, accounting for 1 in 20 deaths in the United States. 10 Early treatment is crucial in maximizing the benefit of stroke interventions such as thrombolytics and thrombectomy for ischemic stroke 11 and blood pressure control for hemorrhagic stroke. 12 Delayed treatments are associated with increased risk of serious long-term disability and death from stroke. 13, 14 We analyzed Medicare data among Medicare fee-for-service (FFS) beneficiaries aged ≥65 years who were hospitalized with a stroke from January 1, 2019, to October 31, 2020, to understand the changes in weekly stroke hospitalizations that occurred during the COVID-19 pandemic and to assess if the change in weekly rate of stroke hospitalization during the pandemic differed by patient characteristics or geographic location.

The Medicare data used in this study cannot be shared by authors because of the data use agreement, but the investigators can request the data access through Centers for Medicare and Medicaid Services.

We identified all Medicare FFS beneficiaries aged ≥65 year with at least 11 months of continuous enrollment in Medicare Part A (hospitalization) and Part B (outpatient care) in 2019 and at least 9 months of enrollment in 2020. We To examine the timing and duration of reductions in stroke hospitalizations, we conducted trend analyses on the weekly number of stroke hospitalizations from week 1 in 2019 through week 44 in 2020 by stroke type (all-stroke, AIS, and hemorrhagic stroke) and by age group (65-74, 75-84, and ≥85 years), sex, race/ethnicity (non-Hispanic White, non-Hispanic Black, Hispanic, and other) as supplemental material using Joinpoint Regression Program (version 4.8.0.0, National Cancer Institute); we calculated the weekly percentage change (WPC) in stroke hospitalizations for each trend segment. We limited modeling to a maximum of 3 joinpoints with 4 trend segments and used the weighted Bayesian Information Criterion for model selection.

To quantify the magnitude of stroke hospitalization changes during the early weeks of the COVID-19 pandemic, when compared with the same time periods in the previous year, we compared the total number of stroke hospitalizations for 2 periods of time based on the Joinpoint results: weeks 10 through 23 in 2020 (compared to same weeks in 2019) to assess the initial impact of the COVID-19 pandemic and weeks 24 through 44 in 2020 (compared to the same weeks in 2019) as the period of the pandemic after the initial impact. Comparisons were by age group, sex, and race/ethnicity and tested for differences based on χ 2 tests and presented adjusted P values by using Holm method for multiple comparisons. 15 To evaluate changes in stroke hospitalizations by patient state of residence, we compared stroke hospitalizations during weeks 10 through 23 in 2019 (the pre-COVID-19 period) to hospitalizations during weeks 10 through 23 in 2020 (during the COVID-19 pandemic) within each state. We calculated the median age and length of hospital stay (interquartile range) pre-COVID-19 and during the COVID-19 pandemic and tested for differences in the median based on Mood method of the RVAideMemoire package in R software. We also estimated in-hospital death rates. We calculated the percent reduction of stroke hospitalizations during 2 time periods: between weeks 10 through 23 in 2019 and 2020 and between weeks 24 through 44 in 2019 and 2020. We divided the difference in number of stroke hospitalizations between 2019 and 2020 (numerator) by the number of stroke hospitalizations in 2019 (denominator) and multiplied by 100. We used bootstrap resamples with 1000 bootstrap samples to determine the 95% CI with lower 95% CI <0 as insignificant change. 16 The study findings are reported in accordance with the Reporting of Studies Conducted Using Observational Routinely Collected Health Data recommendations (Figure I in the Data Supplement shows the study flow diagram). 17 

The weekly number of all-stroke hospitalizations decreased slightly from week 1 in 2019 through week 9 in 2020 (WPC, −0.08% [95% CI, −0.14% to −0.02%]), followed by a sharp decline from week 10 through week 15 (Table 2) . Although the differences in the median length of stay were significant (P<0.05) because of the large sample size, the median and interquartile range remained the same. The number of stroke deaths decreased from 2019 to 2020, but there were no differences in in-hospital death rates comparing prepandemic to the COVID-19 pandemic period ( 

We observed a sharp decline in the number of weekly stroke hospitalizations from weeks 10 through 15 in 2020 (WPC, 5.98%) among Medicare FFS beneficiaries aged ≥65 years followed by an increase during weeks 15 through 23 to levels slightly below those seen during the same weeks in 2019. However, changes in stroke hospitalizations during the initial period of COVID-19 pandemic (weeks 10 through 23) varied significantly by state.

Several studies reported significant reductions in stroke patients admitted to hospitals during the early phase of COVID-19 pandemic in the United States and in other countries. 3, 4, 6, 9, [18] [19] [20] [21] [22] [23] [24] Although most of these studies focused on the initial decline of stroke hospitalizations amidst the COVID-19 pandemic, our study examined the timing, duration, and magnitude of the reduction by including more recent data with longer trend analysis. Based on the National Inpatient Sample of the Healthcare Cost and Utilization Project, there were 579 825 all-stroke hospitalizations in 2017 among years in the vstrokes that occurred after hospital admission). Further studies are needed to determine the consequences of hospitalization avoidance in older stroke patients. Studies have suggested that SARS-CoV-2 infection is associated with increased risk of stroke. 25, 26 Under these circumstances, one may expect to see a continued increase in stroke hospitalizations as the pandemic continues. The reasons for lower than expected stroke hospitalizations following the initial impact of COVID-19 pandemic are not clear; further studies are needed to better understand the reasons why stroke hospitalizations are lower during a pandemic that likely increases stroke risk and to explore the impact of lower hospital-seeking behavior. The observed reduction in stroke hospitalizations increased with increasing age. Studies suggest that older adults tend to overlook the signs of stroke and delay seeking care. 27, 28 Among older adults, those living alone or with less caregiver support are more likely to experience a prehospital delay in stroke treatment and care, which may partly explain the larger reduction in stroke hospitalizations by age during the COVID-19 pandemic. 29, 30 In addition, social isolation during the early phase of COVID-19 pandemic may have resulted in missed or untimely recognition of stroke symptoms and lead to a delay in seeking care.

The findings of our study suggest that the reduction in stroke hospitalizations during the early phase of COVID-19 pandemic was similar between men and women and among different racial and ethnic groups consistent with findings of other studies. 3, 23 However, studies have documented significant racial-ethnic disparities in utilization of emergency medical services systems and often delayed arrival at emergency department for stroke treatment and care in the period before COVID-19 pandemic, 31 as well as a disproportionate impact of COVID-19 on persons of color during the COVID-19 pandemic period. 32, 33 In this study, however, it appears that the effect of COVID-19 on the reduction of stroke hospitalizations was proportionally distributed across sex and race/ethnicity groups among Medicare FFS beneficiaries. Further studies may examine whether there may be any differences in the reduction of stroke hospitalizations by socioeconomic status, insurance coverage, healthcare access, rural and urban, and among non-FFS Medicare beneficiaries.

Our study is the first to examine the variations in the reduction of stroke hospitalizations by state. Nine states had nonsignificant differences, and 12 states had a reduction in all-stroke hospitalizations greater than 25% comparing weeks 10 through 23 in 2019 to the same time period in 2020. The reasons for the significant variation in reductions by states are not clear. The states with a smaller number of stroke hospitalizations were more likely to have nonsignificant changes in stroke hospitalizations during the early phase of COVID-19 pandemic, likely partially due to smaller sample sizes. The starting dates, duration, and type of stay-at-home orders varied by states. For example, California started mandatory stay-at-home order on March 19 and South Carolina on April 6, 2020, and 6 states did not have mandatory stayat-home orders during March and May 2020 (Arkansas, Iowa, Nebraska, North Dakota, South Dakoda, and Wyoming) (https://www.nashp.org/governors-prioritizehealth-for-all). The differences in starting dates, duration, type of stay-at-home orders, and the timing of the geographic spread of SARS-CoV-2 may also contribute to states variations in percent reduction of stroke hospitalizations. Further studies are needed to examine the reasons for the significant variation in the reduction of stroke hospitalizations by states because of the COVID-19 pandemic.

Our findings showed the percent reduction in AIS hospitalizations was greater than that of hemorrhagic stroke. Other studies found that the decline in the number of patients admitted with mild strokes (a National Institutes of Health Stroke Scale score ≤5) was greater than that of moderate or severe strokes in the United Kingdom and Norway, 34, 35 and the preliminary findings from Paul Coverdell National Acute Stroke Program suggested the National Institutes of Health Stroke Scale was significantly higher among hospitalized stroke patients comparing pre-COVID-19 and during the COVID-19 pandemic time periods (Paul Coverdell National Acute Stroke Program, personal communication, October 5, 2020). Despite more moderate or severe stroke were admitted to the hospitals during the pandemic, our study found no differences in inhospital death rates among Medicare beneficiaries comparing prepandemic to the COVID-19 pandemic period consistent with the findings of other studies. 36, 37 Studies suggested that stroke treatments and quality of care were preserved during the pandemic that may partly explain the lack of temporal change in death rates. [36] [37] [38] [39] Hemorrhagic stroke is generally more severe than AIS and associated with considerable risk of mortality. 40 The severity of hemorrhagic stroke may partly explain the differences in reduction of AIS and hemorrhagic stroke hospitalizations as a result of COVID-19 pandemic. However, information on stroke severity was not available in Medicare data. The smaller number of hemorrhagic stroke hospitalizations compared to AIS may also contribute to the finding of fewer reductions that were statistically significant.

Significant reduction in stroke hospitalizations may be due to multiple reasons, including fear of exposure to COVID-19 in hospitals or healthcare settings, stayat-home orders, and social distancing guidance that may make people more likely to be alone, or there could be true changes in incidence of stroke. 4, 5, 19, 41, 42 In addition, it is possible that some hospitalized FFS beneficiaries with COVID-19 having stroke may be classified as COVID-19 instead of stroke. Further study is needed to determine the effect of deferred care-seeking behavior and changes in incidence of stroke on the reduction of stroke hospitalizations during COVID-19 pandemic.

Stroke is the fifth leading cause of death in the United States, and approximately every 40 seconds, an American will experience a stroke. 10 This life-threatening condition requires timely emergency care to avoid serious complications, long-term disability, or death regardless of the COVID-19 pandemic status. 4 As part of its framework for provision of non-COVID-19 health care during the COVID-19 pandemic, the Centers for Disease Control and Prevention recommends seeking timely healthcare for non-COVID-19 time-sensitive conditions, such as stroke and heart attack during COVID-19 (https:// www.cdc.gov/coronavirus/2019-ncov/hcp/frameworknon-COVID-care.html). The Stroke Council of the American Heart Association/American Stroke Association published guidelines for the care of stroke patients and for reducing the risk of infectious exposure at hospital or health care settings during the COVID-19 pandemic. 43, 44 It is recommended that patients seek immediate care for life-threatening conditions like stroke (https://www.cdc. gov/stroke/signs_symptoms.htm).

There are several limitations of this analysis. First, this study used the Medicare preliminary data that is updated on monthly basis and the latest data included in our analysis (week 44 in 2020, October 25-October 31) was updated in January 2021. The number of weekly stroke hospitalizations may be subject to change. However, Centers for Medicare & Medicaid Services suggested that >95% of Medicare FFS in-hospital claims were received within 3 months (https://www.cms.gov/files/document/ medicare-covid-19-data-snapshot-fact-sheet.pdf). Second, Medicare inpatient claims have no information on the severity of stroke; therefore, we could not assess potential differences in the reduction of stroke hospitalizations by severity. Third, Medicare data is an administrative claims database that has important strengths, including the ability to answer a wide range of health care-related questions such as understanding the epidemiology of the chronic diseases, quantifying the costs related to health care interventions, and studying the effects of policy changes on prescribing patterns and clinical outcomes, but it is not designed to be a surveillance system or to track the trends and changes in time-sensitive conditions, including stroke. In addition, the coding of stroke diagnosis using International Classification of Diseases, Tenth Revision in Medicare databases may not reflect the final diagnosis by the treating physicians. However, studies suggested that the sensitivity of International Classification of Diseases, Tenth Revision codes for any cerebrovascular disease (I60-I69) in the administrative health databases was over 80%. 45 Fourth, Medicare databases do not have information on the duration of prehospital delay between the time of stroke symptoms onset and seeking medical care. This information may be particularly important during the pandemic. Fifth, we had limited sample size to examine the timing and duration of weekly reduction in stroke hospitalizations at state level and focused on comparing the difference during the initial effects of COVID-19 pandemic by state. Sixth, we restricted our study to Medicare FFS beneficiaries which included about 60% of Medicare beneficiaries, thus our findings may not be generalizable to non-FFS beneficiaries. About 80% of Medicare beneficiaries in this study identified as non-Hispanic Whites, and our findings may reflect primarily the changes in stroke hospitalizations among non-Hispanic White beneficiaries.

Our findings suggest that the number of stroke hospitalizations was reduced significantly during the early phase of COVID-19 pandemic compared with the same period in 2019 among Medicare FFS beneficiaries and remained at a lower than usual level following the initial impact of pandemic in the United States. Public health agencies and other organizations should enhance communication efforts to remind the public about the signs and symptoms of stroke. Stroke is a medical emergency, Stroke. 2021;52:3586-3601. DOI: 10.1161/STROKEAHA.121.034562 

Mitigation Policy Analysis Unit. Timing of state and territorial COVID-19 stay-at-home orders and changes in population movement -United States

Preserving elective surgeries in the COVID-19 pandemic and the future

Stroke code presentations, interventions, and outcomes before and during the COVID-19 pandemic

Potential indirect effects of the COVID-19 pandemic on use of emergency departments for acute lifethreatening conditions -United States

The curious case of the missing strokes during the COVID-19 pandemic

Decline in stroke presentations during COVID-19 surge

The COVID-19 pandemic and the incidence of acute myocardial infarction

Effect of the COVID-19 pandemic on ST-segment-elevation myocardial infarction presentations and in-hospital outcomes

Acute stroke in times of the COVID-19 pandemic: a multicenter study

Heart disease and stroke statistics-2021 update: a report from the

Stroke Thrombolysis Trialists' Collaborative Group. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials

3595 trial (INTER-ACT): a randomised pilot trial

Delays in door-to-needle times and their impact on treatment time and outcomes in get with the guidelinesstroke

Association of get with the guidelines-stroke program participation and clinical outcomes for medicare beneficiaries with ischemic stroke

A simple sequentially rejective multiple test procedure

An Introduction to the Bootstrap

RECORD Working Committee. The REporting of studies conducted using observational routinely-collected health data (RECORD) statement

Emergency ambulance services for heart attack and stroke during UK's COVID-19 lockdown

Collateral effect of COVID-19 on stroke evaluation in the United States

Underutilization of health care for strokes during the COVID-19 outbreak

Acute stroke care is at risk in the era of COVID-19: experience at a comprehensive stroke center in Barcelona

Delayed presentation of acute ischemic strokes during the COVID-19 crisis

The effect of COVID-19 on stroke hospitalizations in New York City

Decline in stroke alerts and hospitalisations during the COVID-19 pandemic

Risk of ischemic stroke in patients with coronavirus disease 2019 (COVID-19) vs patients with influenza

Increased risk of acute stroke among patients with severe COVID-19: a multicenter study and meta-analysis

Causes of prehospital delay in stroke patients in an urban aging society

Delay or avoidance of medical care because of COVID-19-related concerns -United States

A comprehensive review of prehospital and in-hospital delay times in acute stroke care

Response to symptoms and prehospital delay in stroke patients. Is it time to reconsider stroke awareness campaigns?

2020 as initial impact of COVID-19 pandemic weeks. †% reduction of stroke hospitalization between 2019 and 2020 is calculated as (2019-2020)/(2019)×100 and the bootstrap resamples were used to determine the 95% CI. ‡P value to test for difference in median age or length of stay between 2019 and 2010 and P value to test difference in distribution by age group, sex, race/ethnicity, and in-hospital death between 2019 and 2020 based on χ 2 test and presented adjusted P values by Holm method for multiple comparison

Figure 2. Percent reduction of stroke hospitalizations comparing weeks 10 through 23 in 2019 and 2020 among Medicare feefor-service beneficiaries aged ≥65 y by stroke type and State

June 6) as the initial impact of the COVID-19 pandemic weeks. (Continued) Association Stroke Council; Council on Cardiovascular Nursing; Council on Epidemiology and Prevention; Council on Quality of Care and Outcomes Research. Racial-ethnic disparities in stroke care: the American experience: a statement for healthcare professionals from the American Heart Association/American Stroke Association

COVID-19 State, Tribal, Local, and Territorial Response Team. Disparities in incidence of COVID-19 among underrepresented racial/ethnic groups in counties identified as hotspots during

Coronavirus disease 2019 case surveillance -United States

What has caused the fall in stroke admissions during the COVID-19 pandemic?

Effect of COVID-19 pandemic on stroke admission rates in a Norwegian population

Acute stroke presentation, care, and outcomes in community hospitals in Northern California during the COVID-19 pandemic

Acute ischemic stroke in patients with COVID-19: an analysis from get with the guidelines-stroke

Influence of the COVID-19 pandemic on treatment times for acute ischemic stroke: the society of vascular and interventional neurology multicenter collaboration

Impact of the COVID-19 outbreak on acute stroke care

Hemorrhagic and ischemic strokes compared: stroke severity, mortality, and risk factors

Where are all the patients? Addressing COVID-19 fear to encourage sick patients to seek emergency care

Lockdown Britain: evidence for reduced incidence and severity of some non-COVID acute medical illnesses

Emergency Neurovascular Care (ENCC), the Telestroke and the Neurovascular Intervention Committees. Prehospital triage of acute stroke patients during the COVID-19 pandemic

Temporary emergency guidance to us stroke centers during the coronavirus disease 2019 (COVID-19) pandemic: on behalf of the American Heart Association/American Stroke Association Stroke Council Leadership

Validity of diagnostic codes for acute stroke in administrative databases: a systematic review

We thank Dr Mary G. George, Division for Heart Disease and Stroke Prevention, Centers for Disease Control and Prevention (CDC), for her insightful comments and suggestions on early version of the manuscript.

None.

The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.

Online Figure I Online Table I